Nevertheless, the use of cholesterol-lowering drugs, such as statins or fibrates, in melanoma is controversial [32,33], specifically in terms of its potential to increase PCSK9 [34], which is associated with platelet reactivity, leading to acute coronary syndrome. This evidence concerns the gene PCSK9 and acute coronary syndrome.